It was an cross-sectional study. One hundred and twenty one end stage renal disease (ESRD) patients on maintenance HD, 88 male, 33 female, mean age 51.88 years (range 14-85 years) were included in this study. Clinical and laboratory data such as age, sex aetiology of End Stage Renal Disease (ESRD), HBsAg and anti HCV, HBeAg, PCR for HCV RNA, serum bilirubin, ALT, AST, albumin were examined.
Introduction
Viral hepatitis complicating haemodialysis (HD) has been recognized from the earliest days of this therapy. While the introduction of vaccination programs and stringent infection control measures have succeeded in limiting the spread of hepatitis infection within dialysis facilities outbreaks continue to occur periodically and prevalence rates remain unacceptably high. As such Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection in dialysis patient present a distinct clinical problem in view of the immunosuppressive effect of renal failure, the susceptibility for de-novo infection and nosocomial transmission and the long term implications on morbidity and mortality 1 .
HBV infection is a substantial global health problem. 
Results
Among 121 patients about 75% patients were between age 40 and 70, only 8.3% were below 30 years. Age ranged from 14-85 years with mean age was 51.88 years. 88 (72.7%) of them were male, 33 (27.3%) were female ( Table-I and II) .
Table-I:
Age distribution of the study population (n=121). In this study 8 patients (6.6%) were HBsAg positive, 30 patients (24.8%) were Anti HCV positive, 03 patients were positive for both HBsAg and Anti HCV. Among total 11 patients who were HBsAg positive, 9(81.8%) were found HBeAg positive. HCV RNA were detected in 25/33 patients (75.7%) by PCR technique (Table-IV) . 
Discussion
In patients on maintenance HD, the risk of hepatitis is still a serious problem. Available data suggests that HCV has become the most common cause of hepatitis 13 . In this study prevalence of HBsAg was 9% (11/121), anti Blood and its components (plasma, serum, albumin etc) are the main source of HCV infection. In recent years, an increasing role has been assigned to hospital transmitted infections (nosocomial) 21 . The main reasons for high prevalence of HCV infections are lack of standard infection precautions and lack of effective vaccination, inadequate disinfection of dialysis machines and to the medical equipments as well as infection transmission from patient to patient, especially in dialysis centre with high percentage of infected patients 22 .
Anti HCV antibody positive patients had been on dialysis for 68 (±35.9) months, got 29.96 (± 21.63) units of blood transfusion. There was significant correlation between HCV positivity and duration of HD and number of blood transfusion (P<0.001). Study result is similar to the study of Souza et al and Chawla et al 23, 24 . 
Conclusion
Hepatitis B and Hepatitis C Virus infections remain a major health issue in ESRD population having significant impact on overall morbidity and mortality. Despite the introduction of effective infection control measures to minimize patient-to-patient transmission and Hepatitis B vaccine, occasional outbreak occurs in dialysis units, usually because of lapses in effective infection control practice. In absence of effective vaccine for preventing HCV infection, prevalence of it is consistently higher than in general population. The course of HBV infection is different in patients with dialysis dependant renal failure. Choosing which patient to treat with antiviral therapy, when and with which drugs, a subject to uncertainty at present, therefore standard precautionary measures must be rigorously followed.
